Researchers renew obsolete concept by using folate for cancer drug delivery

by Raymond A. Macdougall,National Institutes of HealthImages of cancer tumor cells taken with a confocal laser scanning microscope. The top row of images show that the anti-cancer formulation de

Updated on: June 15,2024

Researchers renew obsolete concept by using folate for cancer drug delivery

by Raymond A. Macdougall,National Institutes of HealthImages of cancer tumor cells taken with a confocal laser scanning microscope. The top row of images show that the anti-cancer formulation de

Updated on:June 15,2024

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on: January 21,2024

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on:January 21,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024

New leukemia drug is more effective and easier to use

by Loyola University Health SystemA Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaA landmark study

Updated on: March 12,2024

New leukemia drug is more effective and easier to use

by Loyola University Health SystemA Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaA landmark study

Updated on:March 12,2024

New immunotherapy holds promise for ovarian cancer

byKarolinska InstitutetIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) a

Updated on: January 12,2024

New immunotherapy holds promise for ovarian cancer

byKarolinska InstitutetIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (right) a

Updated on:January 12,2024

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Updated on: February 24,2024

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Updated on:February 24,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu

Updated on: January 30,2024

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu

Updated on:January 30,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on: July 17,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on:July 17,2024

Non-melanoma skin cancer killing more people than melanoma, new study finds

by European Academy of Dermatology and VenerologyCredit: Unsplash/CC0 Public DomainNon-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of

Updated on: May 21,2024

Non-melanoma skin cancer killing more people than melanoma, new study finds

by European Academy of Dermatology and VenerologyCredit: Unsplash/CC0 Public DomainNon-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of

Updated on:May 21,2024

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na

Updated on: May 05,2024

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na

Updated on:May 05,2024

Categorizing the epigenetic hallmarks that define cancer

byJosep Carreras Leukaemia Research InstituteThe epigenetic hallmarks of cancer. The illustration depicts the six epigenetic hallmarks that are shared among human malignancies affecting Q8 DNA m

Updated on: October 26,2024

Categorizing the epigenetic hallmarks that define cancer

byJosep Carreras Leukaemia Research InstituteThe epigenetic hallmarks of cancer. The illustration depicts the six epigenetic hallmarks that are shared among human malignancies affecting Q8 DNA m

Updated on:October 26,2024